Mnemo Therapeutics Funding: $90M Raised, Series A (2021)
Mnemo Therapeutics is based in Paris, France. It has raised $90M in total funding. Latest round: Series A.
Mnemo Therapeutics funding overview
Mnemo Therapeutics is based in Paris, France. Mnemo Therapeutics has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2021. The round record for Mnemo Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Casdin Capital, Sofinnova Partners, Redmile, Emerson Collective, Alexandria Venture Investments. 5 distinct backers are named across the disclosed rounds.
Mnemo Therapeutics has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Mnemo Therapeutics?
Casdin Capital, Sofinnova Partners, Redmile, Emerson Collective, Alexandria Venture Investments are named among the investors backing Mnemo Therapeutics.
What was the latest Mnemo Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2021.
Where is Mnemo Therapeutics based?
Mnemo Therapeutics is based in Paris, France.
When did Mnemo Therapeutics last raise?
The last disclosed Mnemo Therapeutics round closed in June 2021 at Series A.
Totals shown for Mnemo Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Paris and the investors behind them below.
